Practise Infectious Diseases Pharmacy Specialty Certification Examination with a short sample and answer explanations. These are independent learning materials, not official exam questions or a pass prediction.
Exam outline and official sources
Board of Pharmacy Specialties (BPS) · BPS BCIDP Examination Specifications, effective October 2025; ECO created October 2024. The assigned workbook label names the awarded credential; it maps to this specialty certification examination.
This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.
- BPS Infectious Diseases Pharmacy
- BPS Examination Content Outlines
- BCIDP Examination Specifications — Effective October 2025
- IDSA 2026 Antimicrobial-Resistant Gram-Negative Infection Guidance
- IDSA 2019 Asymptomatic Bacteriuria Guideline
- IDSA 2016 Candidiasis Guideline
- SHEA/IDSA 2021 Clostridioides difficile Focused Update
- NIH Pneumocystis Pneumonia Guideline
- 2020 ASHP/IDSA/PIDS/SIDP Vancomycin Monitoring Consensus
- CDC Syphilis During Pregnancy
- CDC Management of Persons With Penicillin Allergy
- NIH Hepatitis B Virus Infection — Updated May 27, 2026
- CDC Treatment for Latent Tuberculosis Infection
- IDSA 2018 OPAT Guideline
- CDC Treatment of Uncomplicated Malaria
- CDC Clinical Testing and Diagnosis for Malaria
- CDC Clinical Overview of Shingles
- DailyMed Daptomycin Prescribing Information
- Inhibition of Daptomycin by Pulmonary Surfactant
- DailyMed Apixaban Prescribing Information
- NIH Cryptococcosis Guideline
- NHSN Antimicrobial Use and Resistance Module — July 2026
- CDC Core Elements of Hospital Antibiotic Stewardship Programs
- CDC Keys to Success With the SAAR
- CDC NHSN Antimicrobial Use Analysis FAQs
- FDA Non-Inferiority Clinical Trials to Establish Effectiveness
- CDC C. diff Infection Prevention Guidance — May 13, 2026
Infectious Diseases Pharmacy Specialty Certification Examination
Start with 20 free questions, then review the explanations and any topics you missed.
An Enterobacter cloacae complex bloodstream isolate initially tests susceptible to ceftriaxone. After several days of ceftriaxone exposure, repeat testing of the same strain shows resistance. Which species-associated mechanism most characteristically explains this change?
Infectious Diseases Pharmacy Specialty Certification Examination
Flashcards
Pathophysiology and Epidemiology of Infections
1B2 — Mechanism-specific and associated resistance
Get started with Infectious Diseases Pharmacy Specialty Certification Examination
Purchase your plan, then choose the module to enable. Your plan renews until canceled.
Monthly exam plan
$147 / month
About $4.90 per day
Enable one exam module after payment
Published questions, flashcards and study tools
Renews until canceled
Yearly exam plan
$1337 / year
About $3.66 per day
Enable one exam module after payment
Published questions, flashcards and study tools
Renews until canceled
Found an issue? See our content policy and report a correction.